WASHINGTON, July 2 (Reuters) - GlaxoSmithKline Plc has agreed to plead guilty to criminal charges and pay ${esc.dollar}3 billion to settle the largest case of healthcare fraud in U.S. history, according to court filings and prosecutors.
The settlement includes ${esc.dollar}1 billion in criminal fines and ${esc.dollar}2 billion in civil fines in connection with the sale of the drug company's Paxil, Wellbutrin and Avandia products.
Our Standards: The Thomson Reuters Trust Principles.